Iambic’s physics-informed NeuralPLexer is intended to enhance protein–ligand modeling, enabling broader exploration of ...

Lilly joins the growing list of big pharma companies hoping to see success from their acquired in vivo CAR-T programmes.

Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...

DAVIS, Calif.--(BUSINESS WIRE)--Botanical Solution, a leading producer of advanced botanical materials, has won two awards in the 2024 Pharmaceutical Technology Excellence Awards in the Innovation and ...

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, announced today it has reached a remarkable milestone by winning five categories ...

Hangzhou Yirui Pharmaceutical Technology Co. Ltd. has described N-tetrazolyl aryl urea derivatives acting as bradykinin B1 receptor antagonists reported to be useful for the treatment of age-related ...

Beijing Danatlas Pharmaceutical Technology Co. Ltd. has described heterocyclic derivatives acting as DNA polymerase θ (POLθ, POLQ) inhibitors reported to be useful for the treatment of cancer.

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...